Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

OBJECTIVE: To evaluate the effect of golimumab on physical function, health-related quality of life (HRQOL), and productivity in psoriatic arthritis (PsA). METHODS: GO-REVEAL was a multicenter, randomized, placebo-controlled study. Adult patients with active PsA (n = 405) received golimumab (50 or 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanaugh, Arthur, McInnes, Iain B, Krueger, Gerald G, Gladman, Dafna, Beutler, Anna, Gathany, Tim, Mack, Michael, Tandon, Neeta, Han, Chenglong, Mease, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282022/
https://www.ncbi.nlm.nih.gov/pubmed/23666608
http://dx.doi.org/10.1002/acr.22044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282022/
https://www.ncbi.nlm.nih.gov/pubmed/23666608
http://dx.doi.org/10.1002/acr.22044

Ejemplares similares